Influence of chitosan coating on magnetic nanoparticles in endothelial cells and acute tissue biodistribution

References

• Mahmoudi M, Hofmann H, Rothen-Rutishauser B, et al. Assessing the in vitro and in vivo toxicity of superparamagnetic iron oxide nanoparticles. Chem. Revs. 2011;112:2323–2338. doi:10.1021/cr2002596.
   PubMed Web of Science ®Google Scholar
• Markides H, Rotherham M, El Haj AJ. Biocompatibility and toxicity of magnetic nanoparticles in regenerative medicine. J. Nanomat. 2012;2012: 13. doi: 10.1155/2012/614094.
   Web of Science ®Google Scholar
• Astanina K, Simon Y, Cavelius C, et al. Superparamagnetic iron oxide nanoparticles impair endothelial integrity and inhibit nitric oxide production. Acta Biomater. 2014;10:4896–4911. doi:10.1016/j.actbio.2014.07.027.
   PubMed Web of Science ®Google Scholar
• Michiels C. Endothelial cell functions. J. Cell. Physiol. 2003;196:430–443. doi:10.1002/jcp.10333.
   PubMed Web of Science ®Google Scholar
• Ge G, Wu H, Xiong F, et al. The cytotoxicity evaluation of magnetic iron oxide nanoparticles on human aortic endothelial cells. Nanoscale Res. Lett. 2013;8:215. doi:10.1186/1556-276X-8-215.
   PubMed Web of Science ®Google Scholar
• Jain TK, Reddy MK, Morales MA, et al. Biodistribution, clearance, and biocompatibility of iron oxide magnetic nanoparticles in rats. Mol. Pharm. 2008;5:316–327. doi:10.1021/mp7001285.
   PubMed Web of Science ®Google Scholar
• Cole AJ, David AE, Wang J, et al. Magnetic brain tumor targeting and biodistribution of long-circulating PEG-modified, cross-linked starch-coated iron oxide nanoparticles. Biomaterials. 2011;32:6291–6301. doi:10.1016/j.biomaterials.2011.05.024.
   PubMed Web of Science ®Google Scholar
• Mojica Pisciotti ML, Lima E Jr, Vasquez Mansilla MM, et al. In vitro and in vivo experiments with iron oxide nanoparticles functionalized with DEXTRAN or polyethylene glycol for medical applications: magnetic targeting. J. Biomed. Mater. Res. B Appl. Biomater. 2014;102:860–868. doi:10.1002/jbm.b.33068.
   PubMed Web of Science ®Google Scholar
• Almeida JPM, Chen AL, Foster A, et al. In vivo biodistribution of nanoparticles. Nanomedicine. 2011;6:815–835. doi:10.2217/nnm.11.79.
   PubMed Web of Science ®Google Scholar
• Donaldson K, Stone V, Tran CL, et al. Occup. Environ. Med. 2004;61:727–728. doi:10.1136/oem.2004.013243.
   PubMed Web of Science ®Google Scholar
• Nicolás P, Saleta M, Troiani H, et al. Preparation of iron oxide nanoparticles stabilized with biomolecules: experimental and mechanistic issues. Acta Biomater. 2013;9:4754–4762. doi:10.1016/j.actbio.2012.09.040.
   PubMed Web of Science ®Google Scholar
• Agotegaray M, Palma S, Lassalle V. Novel chitosan coated magnetic nanocarriers for the targeted diclofenac delivery. J. Nanosci. Nanotechnol. 2014;14:3343–3347. doi:10.1166/jnn.2014.8256.
   PubMed Web of Science ®Google Scholar
• Agotegaray M, Lassalle V. Study of the experimental conditions and mechanisms for diclofenac loading in functionalized magnetic nanoparticles. Int. J. Chem. Pharm. Anal. 2014;1: 154–164. http://www.pmindexing.com/journals/index.php/IJCPA/article/view/288.
   Google Scholar
• Kim DH, Lee SH, Im KH, et al. Biodistribution of chitosan-based magnetite suspensions for targeted hyperthermia in ICR mice. IEEE Trans. Magn. 2005;41:4158–4160. doi:10.1109/INTMAG.2005.1463997.
   Web of Science ®Google Scholar
• National Research Council. Guide for the care and use of laboratory animals. Washington (DC): National Academies Press; 2011.
   Google Scholar
• Yeh YC, Hwang GY, Liu IP, et al. Identification and expression of scavenger receptor SR-BI in endothelial cells and smooth muscle cells of rat aorta in vitro and in vivo. Atherosclerosis. 2002;161:95–103. doi:10.1016/S0021-9150(01)00642-6.
   PubMed Web of Science ®Google Scholar
• Campelo AE, Cutini PH, Massheimer VL. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol. Steroids. 2012;77:1033–1040. doi:10.1016/j.steroids.2012.05.008.
   PubMed Web of Science ®Google Scholar
• Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 1951;193:265–275. http://www.jbc.org/content/193/1/265.long.
   PubMed Web of Science ®Google Scholar
• Zysler RD, Lima E Jr, Mansilla MV, et al. A new quantitative method to determine the uptake of SPIONs in animal tissue and its application to determine the quantity of nanoparticles in the liver and lung of Balb-c mice exposed to the SPIONs. J. Biomed. Nanotechnol. 2013;9:142–145. doi:10.1166/jbn.2013.1467.
   PubMed Web of Science ®Google Scholar
• Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 1983;65:55–63. doi:10.1016/0022-1759(83)90303-4.
   PubMed Web of Science ®Google Scholar
• Boyer C, Whittaker MR, Bulmus V, et al. The design and utility of polymer-stabilized iron-oxide nanoparticles for nanomedicine applications. NPG Asia Mater. 2010;2:23–30. doi:10.1038/asiamat.2010.6.
   Web of Science ®Google Scholar
• Hall JE. Guyton and hall textbook of medical physiology. London: Elsevier; 2010.
   Google Scholar
• Anzai Y, Piccoli CW, Outwater EK, et al. Evaluation of neck and body metastases to nodes with ferumoxtran 10-enhanced MR imaging: phase III safety and efficacy study. Radiology. 2003;228:777–788. doi:10.1148/radiol.2283020872.
   PubMed Web of Science ®Google Scholar
• Berry C, Wells S, Charles S, et al. Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials. 2003;24:4551–4557. doi:10.1016/S0142-9612(03)00237-0.
   PubMed Web of Science ®Google Scholar
• Jordan A, Wust P, Scholz R, et al. Cellular uptake of magnetic fluid particles and their effects on human carcinoma cells exposed to AC magnetic fields in vitro. Int. J. Hyperth. 1996;12:705–722. doi:10.3109/02656739609027678.
   PubMed Web of Science ®Google Scholar
• Naqvi S, Naqvi M, Samim M, et al. Concentration-dependent toxicity of iron oxide nanoparticles mediated by increased oxidative stress. Int. J. Nanomed. 2010;5:983–989. doi:10.2147/IJN.S13244.
   PubMed Web of Science ®Google Scholar
• Kou L, Sun J, Zhai Y, et al. The endocytosis and intracellular fate of nanomedicines: implication for rational design. Asian J. Pharm. Sci. 2013;8:1–10. doi:10.1016/j.ajps.2013.07.001.
   Google Scholar
• Gough JE, Scotchford CA, Downes S. Cytotoxicity of glutaraldehyde crosslinked collagen/poly(vinyl alcohol) films is by the mechanism of apoptosis. J. Biomed. Mater. Res. 2002;61:121–130. doi:10.1002/jbm.10145.
   PubMed Web of Science ®Google Scholar
• Ma L, Gao C, Mao Z, et al. Collagen/chitosan porous scaffolds with improved biostability for skin tissue engineering. Biomaterials. 2003;24:4833–4841. doi:10.1016/S0142-9612(03)00374-0.
   PubMed Web of Science ®Google Scholar
• Kim IY, Seo SJ, Moon HS, et al. Chitosan and its derivatives for tissue engineering applications. Biotechnol. Adv. 2008;26:1–21. doi: 10.1016/j.biotechadv.2007.07.009.
   PubMed Web of Science ®Google Scholar
• Varna M, Ratajczak P, Ferreira I, et al. In vivo distribution of inorganic nanoparticles in preclinical models. J. Biomat Nanobiotech. 2012;03:269. doi:10.4236/jbnb.2012.322033.
   Google Scholar
• Li M, Al-Jamal KT, Kostarelos K, et al. Physiologically based pharmacokinetic modeling of nanoparticles. ACS Nano. 2010;4:6303–6317. doi:10.1021/nn1018818.
   PubMed Web of Science ®Google Scholar
• Owens E, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int. J. Pharm. 2006;307:93–102. doi:10.1016/j.ijpharm.2005.10.010.
   PubMed Web of Science ®Google Scholar
• Chouly C, Pouliquen D, Lucet I, et al. Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution. J. Microencapsul. 1996;13:245–255. doi:10.3109/02652049609026013.
   PubMed Web of Science ®Google Scholar
• Aggarwal P, Hall JB, McLeland CB, et al. Nanoparticle interaction with plasma protins as it relates to particle biodistribution, biocompatibility and therapeuic efficacy. Adv. Drug Deliv. Rev. 2009;61:428–437. doi:10.1016/j.addr.2009.03.009.
   PubMed Web of Science ®Google Scholar
• Papisov MI, Bogdanov A Jr, Schaffer B, et al. Colloidal magnetic resonance contrast agents: effect of particle surface on biodistribution. J. Magn. Magn. Mater. 1993;122:383–386. doi:10.1016/0304-8853(93)91115-N.
   Web of Science ®Google Scholar
• Chrastina A, Massey KA, Schnitzer JE. Overcoming in vivo barriers to targeted nanodelivery. Interdiscip. Rev. Nanomed. Nanobiotechnol. 2011;3:421–437. doi:10.1002/wnan.143.
   PubMed Web of Science ®Google Scholar
• Longmire M, Choyke PL, Kobayashi H. Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine. 2008;3:703–717. doi:10.2217/17435889.3.5.703.
   PubMed Web of Science ®Google Scholar